Selective COX-1 Inhibition: A Therapeutic Target to be Reconsidered

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|32|3769-3805

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.32, 2010-11, pp. : 3769-3805

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2253-2266

Bentham Science Publishers

Access to resources Recommend Favorite

Structural and Electronic Factors Influencing the Selective Inhibition of COX-2

By  

Mini Reviews in Medicinal Chemistry, Vol. 16, Iss. 7, 2016-05 ,pp. : 579-594

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase-2 (COX-2) - A Therapeutic Target in Liver Cancer?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 32, 2007-11 ,pp. : 3305-3315

Bentham Science Publishers

Access to resources Recommend Favorite

Prostaglandin E2 synthase inhibition as a therapeutic target

By Iyer Jitesh P   Srivastava Punit K   Dev Rishabh   Dastidar Sunanda G   Ray Abhijit  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 849-865

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase Inhibition as a Therapeutic Target for Brain Ischemia

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 8, 2015-10 ,pp. : 1012-1023

Bentham Science Publishers

Access to resources Recommend Favorite